Basit öğe kaydını göster

EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY

dc.contributor.authorDeltombe, Thierry
dc.contributor.authorWissel, Joerg
dc.contributor.authorWard, Anthony B.
dc.contributor.authorErztgaard, Per
dc.contributor.authorBensmail, Djamel
dc.contributor.authorHecht, Martin J.
dc.contributor.authorLejeune, Thierry M.
dc.contributor.authorSchnider, Peter
dc.contributor.authorAltavista, Maria C.
dc.contributor.authorCavazza, Stefano
dc.contributor.authorDuarte, Esther
dc.contributor.authorGeurts, Alexander C. H.
dc.contributor.authorGracies, Jean-Michel
dc.contributor.authorHaboubi, Naseer H. J.
dc.contributor.authorJuan, Francisco J.
dc.contributor.authorKasch, Helge
dc.contributor.authorKaetterer, Christian
dc.contributor.authorKİRAZLI, YEŞİM
dc.contributor.authorManganotti, Paolo
dc.contributor.authorPaternostro-Sluga, Tatjana
dc.contributor.authorPetropoulou, Konstantina
dc.contributor.authorPrempeh, Robert
dc.contributor.authorRousseaux, Marc
dc.contributor.authorSlawek, Jaroslaw
dc.contributor.authorTieranta, Niko
dc.contributor.authorParman, Yesim
dc.date.accessioned2021-03-03T14:46:28Z
dc.date.available2021-03-03T14:46:28Z
dc.date.issued2009
dc.identifier.citationWissel J., Ward A. B. , Erztgaard P., Bensmail D., Hecht M. J. , Lejeune T. M. , Schnider P., Altavista M. C. , Cavazza S., Deltombe T., et al., "EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY", JOURNAL OF REHABILITATION MEDICINE, cilt.41, sa.1, ss.13-25, 2009
dc.identifier.issn1650-1977
dc.identifier.otherav_3b61b41b-c264-4e60-8624-a7ea112a5a54
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/43883
dc.identifier.urihttps://doi.org/10.2340/16501977-0303
dc.description.abstractA group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectREHABİLİTASYON
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSPOR BİLİMLERİ
dc.subjectSosyal Bilimler Genel
dc.subjectSosyal Bilimler (SOC)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectFiziksel Tıp ve Rehabilitasyon
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectSosyoloji
dc.titleEUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY
dc.typeMakale
dc.relation.journalJOURNAL OF REHABILITATION MEDICINE
dc.contributor.departmentKliniken Beelitz GmbH , ,
dc.identifier.volume41
dc.identifier.issue1
dc.identifier.startpage13
dc.identifier.endpage25
dc.contributor.firstauthorID191034


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster